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Abstract
Background: Malaria, a major public health issue in developing nations, is responsible for more
than one million deaths a year. The most lethal species, Plasmodium falciparum, causes up to 90% of
fatalities. Drug resistant strains to common therapies have emerged worldwide and recent
artemisinin-based combination therapy failures hasten the need for new antimalarial drugs.
Discovering novel compounds to be used as antimalarials is expedited by the use of a high-
throughput screen (HTS) to detect parasite growth and proliferation. Fluorescent dyes that bind
to DNA have replaced expensive traditional radioisotope incorporation for HTS growth assays,
but do not give additional information regarding the parasite stage affected by the drug and a better
indication of the drug's mode of action. Live cell imaging with RNA dyes, which correlates with cell
growth and proliferation, has been limited by the availability of successful commercial dyes.
Results: After screening a library of newly synthesized stryrl dyes, we discovered three RNA
binding dyes that provide morphological details of live parasites. Utilizing an inverted confocal
imaging platform, live cell imaging of parasites increases parasite detection, improves the spatial and
temporal resolution of the parasite under drug treatments, and can resolve morphological changes
in individual cells.
Conclusion: This simple one-step technique is suitable for automation in a microplate format for
novel antimalarial compound HTS. We have developed a new P. falciparum RNA high-content
imaging growth inhibition assay that is robust with time and energy efficiency.
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Background
Malaria continues to be a major public health issue in
many parts of the developing world [1]. Each year 300 to
500 million new clinical cases are officially reported. In
the mid-fifties, the World Health Organization (WHO)
launched a worldwide malaria eradication campaign
using effective and inexpensive therapeutics and insecti-
cides in designated malaria-infected areas. The program
resulted in the elimination of endemic malaria in devel-
oped countries and a significant reduction of cases in
developing parts of the world. The emergence of chloro-
quine-resistant parasites and DDT-resistant mosquito vec-
tors has led to a reappearance and spread of malaria in
most of the developing world. With the absence of an effi-
cient vaccine, worldwide resistance to all commonly used
antimalarial drugs (quinine, aminoquinolines and anti-
folate derivates), and the concern of emerging resistance
to our last defense against this disease (artemisinin-based
combination therapies) [2], there is a dire need for new
antimalarial strategies.
One approach to the discovery of new therapeutic agents
involves the identification of inhibitory small molecules
through whole parasite-based screens. In such assays,
large collections of small molecule libraries can be tested
against parasite growth in culture. For decades, accurate
and reliable quantitative assessment of the drug effects on
parasite growth has been achieved by blood smear micro-
scopic examinations and in vitro measurement of parasitic
uptake of radioactive substrates [3-5]. However, these
methods are relatively expensive, require multi-step pro-
cedures and are time-consuming. They become impracti-
cal as technology advances and the volume of small
molecule libraries increases. Over the past few years, a
number of new techniques have been developed to
improve the cost and compatibility for today's automated
high-throughput screening (HTS) facilities. These tech-
niques include colorimetric assays [6]; such as, fluores-
cence-based assays that measure parasite nucleic acids
using fluorescent dyes (e.g. Hoechst [7,8], PicoGreen® [9],
SYBR Green I [10,11], YOYO-1 [12] and DAPI [13]), or
stable expression of chimeric fluorescent protein [14]. All
these techniques have been used and adapted in auto-
mated or semi-automated HTS analyses using microplate
readers or flow cytometry, and have proven to be reliable
and cost-effective [12,13,15,16]. However, while these
techniques allow the quantification of parasite growth in
human erythrocyte cultures, they detect an average
response from the whole population and are inapt to effi-
ciently detect the drug effect at the morphological level.
Morphological analysis can give additional information
regarding the parasite stage affected by the drug and even-
tually an indication of the drug's mode of action. For such
analyses, investigators are still compelled to examine
Giemsa-stained infected blood smears under brightfield
microscopy [15-17]. While today this methodology can
be completed using a semi-automatic image analysis sys-
tem [18], it requires a laborious multi-step preparation of
fixed, stained blood smears and an experienced techni-
cian.
Recently, the development of high-throughput cellular
imaging has emerged as a crucial tool to allow the integra-
tion of biologically complex effects into drug discovery.
Such techniques can overcome the limitations of cellular-
based high-throughput screening that measure a "simple"
survival count by detecting morphological changes of
individual cells in a microplate well. Cellular imaging
technologies have been used in all stages of drug discovery
including target discovery or mode-of-action studies [19].
When confocal microscopes and image-analysis tools are
combined, cellular imaging platforms can facilitate the
detection of cytotoxicity or cellular phenotypic changes in
a cell population, and lead to the discovery of new drug
targets [20]. Membrane permeable fluorescent molecules
have been one of the most viable tools for live cell imag-
ing technology [13]. Several permeable dyes, such as
nucleic acid dyes (e.g. Hoechst), are commercially availa-
ble and have been used in malaria high-throughput
screening. While DNA measurement has been shown to
be efficient in detecting parasite growth in the high-
throughput screening format, the use of such dyes for par-
asite structural analysis is limited. Specific RNA quantifi-
cation, which also correlates with cell growth and
proliferation, could significantly increase parasite detec-
tion and improve the spatial and temporal resolution of
the malaria parasite under drug treatment. However, cell-
permeable RNA specific dyes are not readily available and
are limited in their successful use, even though the exploi-
tation of both permeate DNA and RNA dyes would be par-
ticularly valuable for high-throughput screening and
high-content imaging in Plasmodium.
To identify malaria parasite specific RNA probes that
could improve live cell microscopy imaging, we have
screened a combinatorial library of 125 fluorescence styryl
molecules [21,22] with infected red blood cells in a
microplate format. Microplates were analyzed using the
BD Pathway HT, an automated confocal imaging worksta-
tion. This inverted confocal microscope with temperature
and carbon dioxide regulation chamber allows suspen-
sion cultures to be viewed without a fixation step. Four-
teen dyes were found to have fluorescence intensity
comparable or superior to DAPI staining. Out of the four-
teen dyes, three dyes displayed a higher affinity to RNA.
They exhibit a specific RNA staining pattern representative
of the different morphological stages of the malaria para-
site erythrocytic cycle. Using the identified RNA dyes and
a high-throughput confocal imaging system, we have
developed a sensitive and simple one-step fluorescence-
based assay for use in Plasmodium high-content imaging.
Inhibitory concentrations of known antimalarials usingBMC Cell Biology 2009, 10:45 http://www.biomedcentral.com/1471-2121/10/45
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our image-based assay were similar to current nucleic acid
dye and spectrophotometer assays. This new technology is
expected to enhance the malaria drug discovery program
and could eventually be adapted as an automated solu-
tion to screen parasitemia in infected patients.
Methods
P. falciparum Culture
3D7 and Dd2 P. falciparum malaria parasites (MRA-102,
156, MR4, ATCC® Manassas, Virginia) were cultured in
human type O+ erythrocytes in complete medium (RPMI
1640, 10 mg/ml Gentamicin (Gibco), 1.36 g/l Hypoxan-
thine (Acros), 1 M HEPES (Sigma), 7.5% Sodium Bicarbo-
nate (Gibco), 20% Glucose (MP Biomedical), 1 M NaOH
(Sigma), 20% Albumax (Gibco), 5% human serum) as
previously described [23]. Cultures were maintained in
25-cm2 flasks (Corning) at a volume of 10 ml and were
gassed for 30 s with an environment of 3% CO2, 1% O2,
and 96% N2, then incubated at 37°C. Synchronization of
culture was achieved through sorbitol lysis of mature stage
using 5% sorbitol (Fisher) fine-tuned by another lysis 8
hours later [24].
Dye Preparation
Microwell plates already containing a library of RNA-
probes were diluted in DMSO to 10 mM. A screening of
125 different RNA-probes were performed by diluting
infected erythrocytes to 0.025% hematrocrit with a 6%
parasitemia into optical bottom 96-well assay plates (Cos-
tar #3614, Corning, NY) containing 240 μl of complete
medium. RNA-probes were added to a final concentration
of 1 μM, 5 μM, 7.5 μM, and 10 μM with a total DMSO
level of 0.5%. Plates were incubated in the dark for 30
minutes at 37°C. During microscopic analysis, the BD
Pathway HT (BD Biosciences Bioimaging, Rockville, MD)
temperature was regulated at 37°C. Each well was fluores-
cently imaged using fluorescence combinations of Sem-
rock (Rochester, NY) DAPI, CFP, GFP, YFP and Texas Red
BrightLine filter sets. We found that 5 μM was the optimal
working concentration.
RNA versus DNA specificity solution assay
DNA was extracted from P. falciparum using an adapted
phenol/chloroform extraction. Infected erythrocytes were
harvested and brought to a 50% hematocrit in PBS. Sam-
ples were incubated with cell lysis solution (Promega
#A7933, Madison, WI) for 10 minutes at room tempera-
ture, followed by centrifugation. After removing the
supernatant, pellet was incubated at 55°C for an hour in
lysis buffer containing 4 M guanidine HCl (Promega),
10% SDS (Promega), and 20 mg/ml Proteinase K (New
England Biolabs), and left overnight at 4°C. DNA was
then extracted using Phenol/chloroform/isoamyl alcohol
(Sigma) following the standard procedures.
RNA was extracted from infected erythrocytes with Trizol
LS (Life Technology), as previously described in Le Roch
et. al. 2003 [23].
To scan fluorescence emission, the SpectraMAX Gemi-
niEM (MDS Analytical Technologies, Toronto, Canada)
and the SoftMax Pro program were used. Using black,
clear bottom, 96-well assay plates (Costar #3904), 10 two-
fold serial dilutions were performed with extracted DNA
and RNA starting at 200 μg/ml. Steady state concentra-
tions of RNA or DNA at 10 μg/ml, were mixed with two-
fold serial dilutions of the opposing nucleic acid. 132A,
107E, and 107F RNA probes were added to wells at a 10
μM concentration. Endpoint readings with an excitation
of 500 nm, cutoff at 515 nm and emission of 605 nm for
132A, and excitation of 435 nm, cutoff at 605 nm and
emission of 610 nm for 107E and 107F. DNA and RNA
concentration as a function of fluorescence intensity was
plotted with SigmaPlot.
Counter Stain
Synchronized infected erythrocytes were stained with
nuclear dye DAPI (Molecular Probes #D21490, Eugene,
OR) or Hoechst 34580 (Molecular Probes #H21486,
Eugene, OR) diluted in H2O and added to reach a final
concentration of 20 ng/μl or 5 μg/ml respectively. RNA
specific dyes were then added to reach a concentration of
5 μM and plates were incubated with both dyes in the dark
at 37°C for 30 minutes. Images were taken using the BD
Pathway HT with the temperature regulated at 37°C. A
macro, an instruction set for the Pathway HT, was
designed to take images of the same frame using the DAPI
filter wheel, then the corresponding filter for RNA dye,
then transmitted light, auto focusing for each image, mov-
ing to another frame in the same well, and to repeat in
subsequent wells.
Relative Fluorescence
Synchronized infected erythrocytes were diluted with
uninfected erythrocytes in complete media (i.e. 0%, 1.5%,
3%, 4.5%, 6%). Diluted probes were added to reach a
final concentration of 5 μM, incubated in the dark for 30
min at 37°C and the BD Pathway HT measured fluores-
cence intensity. Data analyses were performed using
Microsoft Excel 2004 for Mac. Data points were graphed
by 1) calculation of the mean of triplicates per sample
condition, 2) subtraction of the fluorescence background,
and 3) conversion to relative fluorescence units.
Quantitative assay evaluation
Three 96-well microplates with parasite-infected erythro-
cytes were used as a positive control, and three micro-
plates with uninfected erythrocytes were used as a
negative control. All plates were diluted to a 0.025%BMC Cell Biology 2009, 10:45 http://www.biomedcentral.com/1471-2121/10/45
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hematocrit, and 6% parasitemia. 107E, 107F, and 132A
dyes were added to microplates and the Pathway HT
determined fluorescence intensity. The formula z' = 1 -
(3SD+ + 3SD-)/|Ave+ - Ave-| was used to caculate the Z'
value. Where SD+ represents the positive control standard
deviation, SD- the negative control standard deviation,
Ave+ the mean value of the positive control, and Ave- the
mean value of the negative control.
IC50
3D7 parasite cultures were incubated with 0.1 nM, 0.4
nM, 1.2 nM, 3.7 nM, 11.1 nM, 33.3 nM, 100 nM, and 500
nM concentrations of chloroquine or artemisinin (Sigma
#C6628-25G, St. Louis, MO) for 72 hours. Dd2 parasite
cultures were incubated with 5 nM, 25 nM, 75 nM, 100
nM, 150 nM, 200 nM, 300 nM, and 500 nM concentra-
tions of chloroquine. RNA dyes were added to reach 5 μM
final concentration and incubated in the dark for 30 min-
utes at 37°C. Microscopic analysis was performed at a reg-
ulated temperature of 37°C. Montage images of 4 by 4
frames were acquired with transmitted light and the corre-
sponding filter for RNA dyes. Images were merged to ver-
ify infected erythrocytes by having the fluorescent target
overlap with visible hemazoin in transmitted light
images. The Pathway HT calculated the parasitemia by
using the Region of Interest (ROI) function to count fluo-
rescent parasites. Parasitemia was determined by manual
counts of fluorescent images and Giemsa-stained blood
smears, and compared to Pathway HT counts. Samples of
identical cultures were taken to perform a SYBR Green
assay as previously described [16]. Data were analyzed
using Microsoft Excel for Mac, and graphs were plotted
using SigmaPlot 10 (Systat).
Results
Screening of styryl dye library and identification of three 
RNA dyes
To identify new parasite RNA dyes, we screened a library
of styryl compounds. Styryl dyes were synthesized and
purified using a condensation reaction between methyl-
ated-pyridine derivatives and aldehydes, as previously
described [21,22]. Cultures were diluted in microplates
and incubated with the styryl compounds for 30 minutes
at 37°C in the dark. Live cell imaging was performed
using the Pathway HT microscope with temperature regu-
lated at 37°C. This automated spinning disk confocal
microscope with a motionless stage allows a monolayer of
erythrocytes to be observed without fixation and minimal
sample disruption. The Pathway HT was programmed to
auto-focus to acquire transmitted light and fluorescent
images in a special optics 96-well microplate format. Our
Pathway HT is customized with high efficiency Semrock
bandpass filters, and samples were imaged with all fluo-
rescence combinations of Semrock DAPI, GFP, FRET, CFP,
YFP, and Texas Red BrightLine filter sets to measure fluo-
rescence intensity of the initial 125 RNA probes screened
(figure 1). From the initial 125 stryrl dyes, fourteen RNA-
probes were found to have fluorescent intensities similar
or superior to 4'-6-diamidino-2-phenylindole (DAPI) and
SYBR Green DNA staining.
Out of the 14 dyes selected, three exhibited a higher affin-
ity to RNA and displayed characteristic nucleolus targeting
with a diffused staining pattern throughout the cytoplasm
in all intraerythrocytic stages observed. Fluorescence
properties of RNA-probes 132A and 107E were analyzed
at the reported excitation 500 and emission 610 [21]. We
found the YFP 500/24 excitation filter and Texas Red 624/
40 emission filter gave the best fluorescent signal with dye
132A; while the long Stokes shift CFP 438/24 excitation
and YFP 542/27 emission filter combination worked best
for 107E and 107F (figure 1). To determine the optimum
working dyes concentration 10 μM, 7.5 μM, 5 μM, and 2.5
μM were tested in infected erythrocytes. Fluorescent
images taken with a 5 μM concentration provided an opti-
mum signal to noise ratio. The three dyes demonstrated a
signal to noise ratio of 14:1 for 107E, 11:1 for 107F, and
16:1 for 132A. The signal to noise ratio of 132A supports
previous findings of the coupound's fluorescent emission
fold range [21]. Little photobleaching and no visible
change in cell morphology due to toxicity were detected
during the analyses (figure 2A). The selected RNA dyes
were sensitive enough to identify small-sized parasites,
merozoites, and provided detailed images to differentiate
between asexual, trophozoite, and early sexual stages of
the malaria parasite (figure 2B).
To determine if the RNA probes specifically target RNA, an
RNA versus DNA specificity solution assay was performed.
132A, 107E, and 107F at a 10 μM concentration were
added to two-fold serial dilutions of P. falciparum RNA
and DNA. Fluorescence intensity as a function of RNA and
DNA concentrations, displayed a higher response when
bound to RNA when compared to DNA (figure 3). These
results correspond to better nucleoli targeting in the live
cell [21]. Furthermore, 132A exhibited a higher response
in fluorescence intensity when bound to RNA in a sample
containing DNA [see additional file 1].
To compare selectivity and sensitivity of our selected dyes
with classical DNA staining, cell cultures were counter-
stained with the nucleic acid stain DAPI and Hoechst.
Dyes 107E, 107F, and 132A efficiently permeated infected
erythrocytes without the aid of lysis buffers or detergents.
132A displayed greater permeable properties and sensitiv-
ity in detecting parasites than DAPI (figure 4A), which is
used in current HT antimalarial screens. High-content
imaging can benefit by using both DNA and RNA dyes to
assist in parasite stage analyses. Synchronized cell cultures
stained with 107E, 107F, and 132A RNA dyes, and theBMC Cell Biology 2009, 10:45 http://www.biomedcentral.com/1471-2121/10/45
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Design of the RNA imaging P. falciparum growth assay Figure 1
Design of the RNA imaging P. falciparum growth assay. Cultures were incubated in a 96-well microplate with antima-
larial compounds in complete medium for 72 hrs under a standard gas environment at 37°C. After the drug incubation period, 
cultures were diluted to a 0.025% hematrocrit to form a monolayer of erythrocytes in a 96-well microplate. RNA dyes were 
added and incubated at 37°C for 30 min to stain parasites in infected erythrocytes. An automated fluorescent microscope, the 
Pathway HT, was used to detect and obtain images of fluorescent stained parasites, as described in Materials and Methods. 
Transmitted light images were also obtained to verify erythrocyte infection. Fourteen dyes were found to have similar intensity 
to DAPI and SYBR Green I in the primary screen. 132A, 107E, and 107F dyes were found to have a higher affinity to RNA, dis-
playing a diffused staining throughout the parasite, in the secondary screening.BMC Cell Biology 2009, 10:45 http://www.biomedcentral.com/1471-2121/10/45
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Morphological analyses Figure 2
Morphological analyses. A) RNA dye staining of P. falci-
parum during schizont, trophozoite, and ring stages of eryth-
rocyte life cycle were colored in green. RNA dyes were 
obtained using excitation 438/24 and emission 542/27 for 
107F and 107E, and a red filter excitation 500/24 and emis-
sion 624/40 for 132A. B) RNA dyes are sensitive enough to 
detect merozoites and gametocytes in culture.
RNA versus DNA specificity solution assay Figure 3
RNA versus DNA specificity solution assay. Fluores-
cence intensity of two-fold serial dilutions of P. falciparum 
RNA and DNA, with a 10 μM concentration of RNA probes. 
Dyes display a higher fluorescence intensity with RNA than 
DNA.BMC Cell Biology 2009, 10:45 http://www.biomedcentral.com/1471-2121/10/45
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DNA-specific dye DAPI, allowed the detection of all para-
site asexual stages (figure 4B). Co-localization was
observed in the nucleus, but RNA dyes targeted the nucle-
olus and diffused throughout the parasite allowing the
visualization of parasite morphology at every erythrocytic
stage of the malaria parasite. These data demonstrate the
capability of RNA dyes to permeate parasite membranes
more efficiently than DAPI staining and significantly
increases the quality of the parasite phenotypic analysis.
Relationship between parasitemia and fluorescence 
intensity and validation of RNA dyes for their use in a high-
throughput malaria growth assay
To determine the relationship between infected erythro-
cytes and relative fluorescence intensity when stained with
RNA dye, we compared the fluorescence intensity to the
percentage of parasite-infected red blood cells. Serial dilu-
tions of infected erythrocytes with 5 μM of RNA dye were
prepared in triplicate and analyzed using the Pathway HT.
As shown in Figure 5, an almost linear relationship
between the percentages of infected red blood cells and
the fluorescence signal was observed with an R2 value of
0.868, 0.959 and 0.916 for 132A, 107E and 107F, respec-
tively. To further validate our assay, we calculated the Z-
factor values for each of the selected dyes. The Z-factor is
a statistical characteristic for HTS assays used to compare
and evaluate the quality of high-throughput assays [25]. A
Z-factor value equal to one is an ideal assay, while values
between 1 and 0.5 are considered excellent. The Z-factor
was determined for each of our three selected dyes in a 96-
well microplate and exhibited 0.689, 0.706, and 0.728 Z'-
values for 107E, 107F, and 132A, respectively. These data
demonstrate the ability to determine parasitemia based
on relative fluorescence units (RFU), and validates the use
of RNA probes for high-throughput live cell imaging.
To ensure that the activities of antimalarials measured by
RNA dye and image analysis were consistent with estab-
Counter-staining analyses using fluorometric DNA and RNA  dyes Figure 4
Counter-staining analyses using fluorometric DNA 
and RNA dyes. A) Counter-staining with DNA dyes dem-
onstrates the sensitivity, permeability and the adequate signal 
to noise ratio of RNA dyes. Hoechst staining has a significant 
amount of background compared to 132A. 132A detected 
parasites that were overlooked by DAPI staining. B) Counter 
staining with nucleic acid dye DAPI, in red, and RNA dyes 
107F, 107E, and 132A, in green, at schizont, trophozoite, and 
ring stages of erythrocytic cycle. Images obtained by the 
Pathway HT were grayscale; red and green colors were arti-
ficially added to emphasize localization.
Evaluation of the percentage of P. falciparum-infected eryth- rocytes using fluorescence intensity obtained by the Pathway  HT Figure 5
Evaluation of the percentage of P. falciparum-
infected erythrocytes using fluorescence intensity 
obtained by the Pathway HT. Serial dilution of synchro-
nized infected cultures (6% parasitemia) of P. falciparum 3D7 
strain were conducted as described in Materials and Meth-
ods. A linear relationship was observed between RFU and 
percentage of infected erythrocytes. Error bars represent 
the standard deviation of the mean from three independent 
samples.BMC Cell Biology 2009, 10:45 http://www.biomedcentral.com/1471-2121/10/45
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lished parasite growth inhibition assays, we measured the
IC50  values of known antimalarials (chloroquine and
artemisinin), and of chloroquine sensitive and resistant
parasite strains using the Pathway HT. The Pathway allows
the detection of fluorescent parasites based on set param-
eters and numbers them according to size and intensity.
Furthermore, the Pathway HT montage function compiles
multiple frames into one tiled image that provides a large
area of observation [see additional file 2]. These data can
then be used to determine percentage of parasite growth
compared to drug dose. IC50 values obtained using RNA
dye high-throughput confocal microscopy assay were
comparable to IC50values measured by the widely used
SYBR Green assay (Figure 6). Data were further validated
by microscopic analyses of Giemsa-stained blood smears
(data not shown). While the IC50 values obtained with the
three selected dyes are closely related to each other, they
did not produce identical results. This can be explained by
the differences observed in signal to noise ratios and the
small disparate Z'-values obtained for each dye. To further
validate the sensitivity of our assay, we calculated the min-
imum parasitemia detected by the Pathway HT above
background. The Pathway HT detected 1 single parasite
out of 12,000 RBCs, corresponding to a 0.0083% para-
sitemia, confirming the sensitivity of the high-content
imaging assay.
To confirm that the developed high-content live cell imag-
ing assay can combine IC50 values with morphological
examination of the parasite under drug treatment, images
obtained with parasite Dd2 and 3D7 strains were com-
pared to Giemsa-stained blood smears (Figure 7). Mor-
phological phenotypes of parasites observed between the
two techniques were highly similar. Using the fluoromet-
ric RNA staining dye 132A, parasites display a loss of
nucleolus staining, and a decrease in signal intensity with
an increase in drug concentration. All together, these data
demonstrate that RNA dyes are sufficiently sensitive and
reproducible to identify the inhibition effects of antima-
larial compounds in a HTS screening and high-content
imaging format.
Discussion
In the past few years, cellular imaging has emerged as a
critical tool to efficiently integrate the cellular complexity
into drug discovery. Continuous technical improvements
in fluorescence, confocal microscopy platforms, and
image analysis have enhanced the detection and
improved the resolution by which an individual molecule
can act in a cell. High-content cellular imaging screenings
recently lead to the discovery of small molecule inhibitors
of novel cellular targets in human cancer cell lines [20].
Technological progress observed in cellular imaging
toward human diseases needs to be adapted to the
Validation of parasite growth inhibition measurement by  known antimalarials Figure 6
Validation of parasite growth inhibition measure-
ment by known antimalarials. IC50 values for 3D7 para-
site cultures treated with chloroquine (A) and artemesinin 
(B) were calculated using images obtained by the Pathway HT 
and compared to the classical SYBR Green assay. C) IC50 val-
ues determined with our high-content assay using fluoromet-
ric RNA dye 132A for parasite chloroquine sensitive 3D7 
and chloroquine resistant Dd2 strains.BMC Cell Biology 2009, 10:45 http://www.biomedcentral.com/1471-2121/10/45
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malaria parasite to enhance its drug discovery program. It
is essential to integrate a spatial and temporal phenotypic
analysis of the parasite under drug pressure in order to
identify small molecule inhibitors that block major spe-
cific parasitic events (e.g. parasite invasion, division or
egress). These types of phenotypic studies will improve
the biological relevance of malaria HTS.
To address this need, we screened a combinatorial library
of fluorescent styryl molecules, which contain RNA prob-
ing compounds that have been successfully identified in
human cell lines [21,22]. Using a confocal microscope
platform, the Pathway HT, we identified three RNA dyes
with strong imaging properties relative to commercially
available DNA dyes in live parasites. The selected dyes,
107E, 107F, and 132A are membrane permeable, diffuse
throughout the cytoplasm to display parasite morphol-
ogy, target nucleoli, and can be used in conjunction with
DAPI staining. Out of the three dyes 132A exhibited the
best signal to noise ratio and Z'-value, therefore this dye
appears to have the best properties and will be used in
future assays. Such characteristics allow the observation of
RNA quantity and distribution in relation to the organiza-
tion of the DNA within the parasite. Simultaneous DNA
and RNA staining significantly increases the cell structural
organization and facilitates the morphological analysis of
Plasmodium in culture. While GFP fluorescence proteins
have been exploited as tools to facilitate the dynamic
behaviors of proteins and parasite phenotype examina-
tion in a real-time manner, these techniques require the
use of modified cell lines, which are not the optimal
choice for a large, small molecule screen against different
Plasmodium drug resistant and sensitive isolates. In addi-
tion, optimum DNA staining, which has been successful
in malaria HTS, requires the addition of lysis buffer and/
or a fixation step that prevents the observation of live par-
asites and increases the screen's complexity. Although it is
possible using DAPI staining to see numerous nuclei in
close enough proximity to identify schizont stages, the dif-
ferentiation between other stages of the erythrocyte life
cycle is more challenging. The use of RNA dye together
with DNA staining provides a dynamic morphology of all
parasite erythrocytic cycle stages. It gives accurate informa-
tion on parasite RNA content and its transcriptional activ-
ity, as well as information on cytotoxicity effects on
erythrocytes and parasites.
Conclusion
In conclusion, our IC50 results clearly demonstrate the fea-
sibility of RNA directed fluorescence-based assays for
high-throughput screening of antimalarials. Furthermore,
these type of HTS and high-content imaging assay analy-
ses can be defined and programmed automatically on the
Pathway HT, avoiding the need of an experienced or
biased microscopist to analyze the images. This new Plas-
modium  RNA dye growth inhibition and high-content
imaging assay is a robust, cost effective, fast, and simple
one-step technique suitable for automation in 96- to 384-
well plates. It will be an ideal technique for a secondary
screen validation, help to determine the stage specificity
of drugs and potentially indicate a drug's mode of action.
When combined with a similar mammalian screen, we
should be able to identify the parasite specific com-
pounds. It is also important to highlight that the sensitiv-
ity of such technique should allow the method to be
adapted for the identification of infected blood samples
of patients.
Abbreviations
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units.
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Morphological analysis of 3D7 and Dd2 parasites using the  Pathway HT Figure 7
Morphological analysis of 3D7 and Dd2 parasites 
using the Pathway HT. Parasite synchronized cultures 
were incubated for 72 hours with various concentrations of 
chloroquine, live-stained with the fluorometric RNA dye 
132A and fixed-stained with Giemsa. Detailed images of 
infected erythrocytes show a decrease in fluorescence inten-
sity, loss of nucleolus staining, and change of parasite mor-
phology with increasing drug concentration.BMC Cell Biology 2009, 10:45 http://www.biomedcentral.com/1471-2121/10/45
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Additional file 1
DNA: RNA binding assay. Graph represents 132A staining of RNA and 
DNA in a mixed population, with one nucleic acid kept at a steady state 
and the other serially diluted, where the maximum fluorescence intensity 
was set to one. Steady state RNA was observed to have a higher fluores-
cence intensity than serially diluted RNA, indicating 132A has a higher 
fluorescent signal when bound to RNA.
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[http://www.biomedcentral.com/content/supplementary/1471-
2121-10-45-S1.jpeg]
Additional file 2
Merged montage images. A tiling of two by two images of transmitted 
light and fluorescent parasites, were taken with the Pathway HT. 
Decreased parasitemia with increasing concentration of chloroquine was 
observed with the 3D7 strain.
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